Reply to ‘Assessing the impact of generative AI on medicinal chemistry’

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Schneider, P. et al. Nat. Rev. Drug Discov. https://doi.org/10.1038/s41573-019-0050-3 (2019).

  2. 2.

    Walters, W. P. and Murcko, M. Nat. Biotechnol. https://doi.org/10.1038/s41587-020-0418-2 (2020).

  3. 3.

    Kadurin, A. et al. Oncotarget 8, 10883–10890 (2016).

  4. 4.

    Gómez-Bombarelli, R. et al. ACS Cent. Sci. 4, 268–276 (2018).

  5. 5.

    Blaschke, T., Olivecrona, M., Engkvist, O., Bajorath, J. & Chen, H. Mol. Inform. 37, 1700123 (2018).

  6. 6.

    Chen, H. & Engkvist, O. Trends Pharmacol. Sci. 40, 806–809 (2019).

  7. 7.

    Zhavoronkov, A. https://bioengineeringcommunity.nature.com/users/290712-alex-zhavoronkov/posts/52978-molecules-imagined-using-advanced-artificial-intelligence-show-promising-results-in-pre-clinical-experiments Nature Research Bioengineering Community (2 September 2019).

  8. 8.

    Zhavoronkov, A. et al. Nat. Biotechnol. 37, 1038–1040 (2019).

  9. 9.

    Canning, P. et al. J. Mol. Biol. 426, 2457–2470 (2014).

  10. 10.

    Polykovskiy, D. et al. Preprint at https://arxiv.org/abs/1811.12823v3 (2018).

  11. 11.

    Kuznetsov, M., Polykovskiy, D., Vetrov, D. P. & Zhebrak, A. A prior of a Googol Gaussians: a tensor ring induced prior for generative models. in Advances in Neural Information Processing Systems 32 4104–4114 (2019).

Download references

Author information

Correspondence to Alex Zhavoronkov.

Ethics declarations

Competing interests

A.Z. is cofounder and CEO of Insilico Medicine, a global artificial intelligence company engaged in drug discovery, biomarker development, clinical trial outcomes prediction and aging research. A.A.-G. is a cofounder and board member of, and consultant for, Kebotix, an artificial intelligence–driven molecular discovery company, and a member of the science advisory board of Insilico Medicine.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhavoronkov, A., Aspuru-Guzik, A. Reply to ‘Assessing the impact of generative AI on medicinal chemistry’. Nat Biotechnol (2020). https://doi.org/10.1038/s41587-020-0417-3

Download citation